Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Thrive Capital

AI overview

Sign in and the AI will write an overview from our coverage.

Headlines · 4

  1. Isomorphic Labs Raises $5 Billion in Series C for AI Drug Design

    Isomorphic Labs, the Alphabet drug discovery company led by Demis Hassabis, raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital, according to The Next Web. Andreessen Horowitz and other new investors joined, while Alphabet and existing investors participated; the company said the round was oversubscribed, but no independent evidence was supplied. Isomorphic plans to use the funding to advance IsoDDE toward clinical trials, expand into additional drug modalities and support more than 20 programmes.

    The Next Web · 🔥 47
  2. Fractile Raises $720M at $7B Valuation for DRAM-Based AI Chips

    London-based chip designer Fractile has raised $720 million in a Series C round at a $7 billion post-money valuation, according to Financial Times-sourced reporting. Thrive Capital, Founders Fund, Lightspeed and Redpoint led the round, while CapitalG, the UK’s Sovereign AI fund, DST Global, BlackRock and other investors also participated. Fractile is developing inference accelerators that combine DRAM and logic in a three-dimensional stack, along with rack-scale systems. The company says the design could provide higher memory bandwidth and make inference up to 10 times faster, but those performance claims have not been demonstrated in a commercial chip. Its first chips and systems are planned for delivery in 2027.

    智东西 · 🔥 0
  3. Isomorphic Labs Talks to Raise $5 Billion at $50 Billion Valuation

    Bloomberg reports that Alphabet-backed Isomorphic Labs is in talks to raise roughly $5 billion for AI drug discovery. The proposed round could value the company at about $50 billion, following its $2.1 billion raise led by Thrive Capital in May. The financing has not closed, and its terms and valuation could change.

    Bloomberg Technology · 🔥 0
  4. OpenAI-backed Thrive Holdings to buy ADT in $7.6B cash deal

    Thrive Holdings, the holding company spun out of Josh Kushner's Thrive Capital, has agreed to buy US home security company ADT for $10 per share in cash, valuing ADT at roughly $7.6 billion in equity and $15.3 billion in total enterprise value, the companies said on Thursday. The price is a 45.6% premium to ADT's October 27 close of $6.87, ADT's board approved the deal unanimously, and funds managed by Apollo Global Management affiliates are providing all of the financing. The transaction still requires ADT shareholder and US antitrust approval, with closing expected in the first quarter of 2027, and the announcement said ADT will form the foundation of Thrive Holdings' smart home security business.

    The Next Web · 🔥 0

Experience and discussion from the community

Share my Thrive Capital experienceAsk about Thrive Capital

Nobody has shared their experience with Thrive Capital yet.